業務咨詢
中國：
Email: marketing@www.msjidi.com
業務咨詢專線：400-780-8018
（僅限服務咨詢，其他事宜請撥打川沙總部電話）
川沙總部電話: +86 (21) 5859-1500
海外：
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
Hypertension is a serious public health problem worldwide. MT-1207 is a chemical entity that has entered into clinical trial as antihypertensive agent. MT-1207 potently inhibits adrenergic α1A, α1B, α1D, and 5-HT2A receptors with Ki<1 nM in a panel of enzyme activity or radioligand binding assays. The binding inhibition activities of MT-1207 were evaluated by Medicilon.
Reference:
Tian-Ying Xu, et al. Pharmacological characterization of MT-1207, a novel multitarget antihypertensive agent. Acta Pharmacol Sin. 2021 Jun;42(6):885-897. doi: 10.1038/s41401-021-00636-1.
川沙總部
地址: 上海市浦東新區川大路585號
郵編: 201299
電話: +86 (21) 5859-1500（總機）
傳真: +86 (21) 5859-6369
海外：
Email:?marketing@medicilon.com
Tel: +1 (617) 888-9294(U.S.)
Tel: 0044 7790 816 954 (Europe)
Tel: +82 70-8269-5849 (Korea)
Tel: +81 80-4421-6898 (Japan)